Connect
MJA
MJA

Letters

Institutional racism in Australian healthcare: a plea for decency

Christopher R Strakosch

Med J Aust 2004; 181 (10): 580 Free

Critical shortage of injectable thiamine in Australia

Simon Spedding and Matt D Gaughwin

Med J Aust 2004; 181 (10): 577-578

Should telemedicine in eye care be funded in Australia?

Sajeesh K R Kumar, Yogesan Kanagasingam and Ian J Constable

Med J Aust 2004; 181 (10): 583

Three Australian whistleblowing sagas: lessons for internal and external regulation

Francis Lannigan, Geoff Knight, Gary C Geelhoed, Alan Duncan, Peter Chauvel, Ian Hewitt and Peter Le Souëf

Med J Aust 2004; 181 (10): 580

Managing medical indemnity: must we choose between quality assurance and risk management?

Paul Nisselle

Med J Aust 2004; 181 (9): 519-520

Missed peptic ulcer: a salutary lesson

Kevin B Orr

Med J Aust 2004; 181 (9): 520

Medical education and hard science

Kevin L Forbes

Med J Aust 2004; 181 (9): 518-518

The expanding phenotype of cystic fibrosis

Janine M Smith and Edwin P E Kirk

Med J Aust 2004; 181 (9): 514

Medical education and hard science

Paul G McMenamin

Med J Aust 2004; 181 (9): 518-518

Obtaining consent affects the value of the Western Australian autism register

Emma J Glasson and John Wray

Med J Aust 2004; 181 (9): 514-515

Medical education and hard science

Martin B Van Der Weyden

Med J Aust 2004; 181 (9): 518-518

Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)?

Patrick G P Charles, Michelle Ananda-Rajah, Paul D R Johnson and M Lindsay Grayson

Med J Aust 2004; 181 (9): 515-516

Managing medical indemnity: must we choose between quality assurance and risk management?

Lionel L Wilson

Med J Aust 2004; 181 (9): 519-520

Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)?

Kirsty L Buising, Karin A Thursky, James F Black and Graham V Brown

Med J Aust 2004; 181 (9): 515-516

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Lloyd N Sansom

Med J Aust 2004; 181 (8): 457-458

Thyroid testing 10 years on

Richard X Davey

Med J Aust 2004; 181 (8): 462-464

Multicentre research: negotiating the ethics approval obstacle course

David J Maxwell and Karen I Kaye

Med J Aust 2004; 181 (8): 459-461

The Australian Government’s Review of Positron Emission Tomography: evidence-based policy decision-making in action

Nat Lenzo

Med J Aust 2004; 181 (9): 516-517

The medical profession and the pharmaceutical industry: when will we open our eyes?

Tim Woodruff

Med J Aust 2004; 181 (8): 458-459

Thyroid testing 10 years on

Jan R Stockigt

Med J Aust 2004; 181 (8): 462-464

Multicentre research: negotiating the ethics approval obstacle course

Martin B Van Der Weyden

Med J Aust 2004; 181 (8): 459-461

The Australian Government’s Review of Positron Emission Tomography: evidence-based policy decision-making in action

Robert E Ware, Hilton W Francis and Kenneth E Read

Med J Aust 2004; 181 (9): 516-517

The medical profession and the pharmaceutical industry: when will we open our eyes?

Linda V Graudins

Med J Aust 2004; 181 (8): 458-459

Preventing intrathecal administration of vincristine

Peter J Gilbar and Christine V Carrington

Med J Aust 2004; 181 (8): 464

Management of obesity

Gordon R W Davies

Med J Aust 2004; 181 (8): 461-462